# Angiotensin-Converting Enzyme (ACE) Inhibitor-Associated Hypersensitivity Vasculitis With Small Bowel Edema: A Case Report

**Authors:** Lamyae Debbagh, Marc Zalcman

PMC · DOI: 10.7759/cureus.103653 · Cureus · 2026-02-15

## TL;DR

An 84-year-old man developed abdominal pain and skin symptoms from an ACE inhibitor, which improved after stopping the drug.

## Contribution

This case report highlights a rare ACE inhibitor side effect involving the small bowel and skin vasculitis.

## Key findings

- ACE inhibitor use was linked to small bowel edema and cutaneous purpura.
- Discontinuation of lisinopril led to rapid symptom resolution.
- CT imaging showed bowel wall thickening without mesenteric ischemia.

## Abstract

Angiotensin-converting enzyme (ACE) inhibitor-associated hypersensitivity vasculitis with gastrointestinal involvement is an uncommon but important drug-related cause of acute abdominal pain and may mimic an acute surgical abdomen. We report the case of an 84-year-old man admitted for redo aortic valve replacement following infective endocarditis, who developed acute abdominal pain on postoperative day 14. Physical examination revealed diffuse abdominal tenderness and cutaneous purpura. Laboratory testing showed elevated inflammatory markers with peripheral eosinophilia. Contrast-enhanced abdominal CT demonstrated concentric small bowel wall thickening with submucosal edema and ascites, without evidence of mesenteric ischemia. Skin biopsy confirmed leukocytoclastic vasculitis. Lisinopril was initiated at the time of admission and continued throughout the perioperative period; symptoms occurred approximately three weeks after treatment initiation, with no prior history of similar episodes. Discontinuation of lisinopril resulted in rapid clinical improvement and complete resolution of abdominal symptoms. This case highlights that ACE inhibitor-associated hypersensitivity vasculitis may present with small bowel edema and imaging findings overlapping with intestinal angioedema. Careful medication review and recognition of associated systemic features such as purpura and eosinophilia are essential to avoid unnecessary invasive procedures.

## Linked entities

- **Chemicals:** lisinopril (PubChem CID 5362119)
- **Diseases:** infective endocarditis (MONDO:0000565), hypersensitivity vasculitis (MONDO:0006794)

## Full-text entities

- **Diseases:** intestinal angioedema (MESH:D007410), abdominal pain (MESH:D015746), abdomen (MESH:D000006), gastrointestinal involvement (MESH:D005767), abdominal symptoms (MESH:D000007), acute (MESH:D000208), leukocytoclastic vasculitis (MESH:C535509), mesenteric ischemia (MESH:D065666), purpura (MESH:D011693), Hypersensitivity Vasculitis (MESH:D018366), ascites (MESH:D001201), inflammatory (MESH:D007249), Small Bowel Edema (MESH:D004487), infective endocarditis (MESH:D004696), eosinophilia (MESH:D004802)
- **Chemicals:** Angiotensin-Converting Enzyme (ACE) Inhibitor (-), Lisinopril (MESH:D017706)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12994090/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12994090/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12994090/full.md

---
Source: https://tomesphere.com/paper/PMC12994090